• Roche buys Foundation Medicine for $2.4 billion financialexpress
    June 29, 2018
    Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine (FMI), raising its bet on the US genomic profiling group’s ability to personalise cancer care.
PharmaSources Customer Service